1 Migraine Symptoms And Diagnosis |
|
1 | (26) |
|
|
1 | (1) |
|
Phases And Clinical Features Of Migraine |
|
|
1 | (15) |
|
Premonitory Phase (Prodrome) |
|
|
|
|
|
|
|
|
|
|
|
|
|
The Classification Of Migraine |
|
|
16 | (11) |
|
|
|
|
|
Migraine Aura Without Headache |
|
|
|
|
|
Complications of Migraine |
|
|
|
Migraine Aura-Triggered Seizure |
|
|
|
Episodic Syndromes That May Be Associated with Migraine |
|
|
|
Migraine Diagnosis Using ID Migraine |
|
|
2 Migraine Genetics |
|
27 | (20) |
|
|
27 | (1) |
|
|
28 | (1) |
|
|
29 | (2) |
|
|
31 | (1) |
|
|
31 | (2) |
|
Implications For Migraine Research |
|
|
33 | (1) |
|
|
34 | (3) |
|
Familial Hemiplegic Migraine: A Monogenic Migraine Subtype |
|
|
|
Genes for Common Migraine Subtypes |
|
|
|
Migraine Genome-Wide Association Studies |
|
|
37 | (3) |
|
|
|
Migraine and Genetic Vasculopathies |
|
|
|
Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts And Leukoencephalopathy |
|
|
40 | (1) |
|
Retinal Vasculopathy With Cerebral Leukodystrophy (RVCL) |
|
|
41 | (1) |
|
Hereditary Systemic Angiopathy |
|
|
41 | (1) |
|
|
42 | (1) |
|
|
42 | (5) |
3 Less Common Migraine Subtypes |
|
47 | (16) |
|
|
47 | (1) |
|
|
48 | (2) |
|
Migraine With Brainstem Aura |
|
|
50 | (2) |
|
|
52 | (1) |
|
|
53 | (1) |
|
|
54 | (3) |
|
|
57 | (1) |
|
|
58 | (5) |
4 Migraine Comorbidity |
|
63 | (22) |
|
Migraine, Cardiovascular, And Cerebrovascular Disease |
|
|
65 | (1) |
|
Pregnancy-Related Hypertension |
|
|
66 | (1) |
|
|
67 | (1) |
|
|
68 | (1) |
|
|
69 | (1) |
|
|
70 | (2) |
|
|
72 | (2) |
|
|
74 | (1) |
|
|
75 | (1) |
|
Association Between Restless Legs Syndrome And Migraine |
|
|
76 | (2) |
|
Migraine, Raynaud's Syndrome, And Other Rheumatologic Disorders |
|
|
78 | (1) |
|
|
78 | (7) |
5 Migraine Pathogenesis |
|
85 | (38) |
|
|
85 | (1) |
|
|
86 | (11) |
|
|
|
|
|
Does Migraine Headache Result from Vasodilation? |
|
|
|
Sensitization In Migraine |
|
|
97 | (4) |
|
|
|
|
|
Does Sensitization Play a Role in Headache? |
|
|
|
|
101 | (2) |
|
|
103 | (2) |
|
|
105 | (6) |
|
What Could Initiate Activation of Trigeminovascular Afferents in the Absence of a Clinical Aura? |
|
|
|
Associated Symptoms Of Migraine |
|
|
111 | (3) |
|
|
|
|
|
|
|
|
114 | (1) |
|
|
114 | (9) |
6 Non-Pharmacologic Therapy |
|
123 | (12) |
|
|
125 | (1) |
|
Cognitive Behavioral Therapy |
|
|
125 | (1) |
|
|
126 | (1) |
|
Behavioral Treatment Approaches |
|
|
126 | (1) |
|
Efficacy Of Behavioral Treatments |
|
|
126 | (1) |
|
Limited And No-Contact Behavioral Interventions |
|
|
127 | (1) |
|
Telephone-Administered Treatment |
|
|
127 | (1) |
|
Internet- And Mass Mediaadministered Treatment |
|
|
128 | (1) |
|
Mindfulness-Based Stress Reduction |
|
|
128 | (1) |
|
|
128 | (1) |
|
Combining Behavioral And Drug Therapy |
|
|
129 | (1) |
|
|
130 | (1) |
|
|
130 | (1) |
|
|
131 | (1) |
|
School-Based Behavioral Interventions |
|
|
131 | (1) |
|
|
131 | (1) |
|
|
132 | (3) |
7 Acute Migraine Therapy |
|
135 | (28) |
|
|
135 | (1) |
|
|
136 | (2) |
|
|
|
|
|
|
|
Use of Adjunctive Medications |
|
|
|
|
|
Avoid Acute Medication Overuse |
|
|
|
|
138 | (6) |
|
Migraine Specific Medications |
|
|
|
Other Migraine-Specific Medications |
|
|
|
|
144 | (6) |
|
Simple Analgesics and NSAIDs |
|
|
|
|
|
Butalbital-Containing Products |
|
|
|
Neuroleptics (Dopamine Antagonists) |
|
|
|
Acute Treatment Guidelines |
|
|
150 | (1) |
|
|
151 | (2) |
|
5-HT 1F Receptor Antagonists |
|
|
153 | (1) |
|
CGRP Receptor Antagonists |
|
|
154 | (1) |
|
|
155 | (8) |
8 Preventive Treatment |
|
163 | (30) |
|
|
163 | (1) |
|
Impact Of Preventive Treatment |
|
|
164 | (1) |
|
Principles Of Preventive Treatment |
|
|
164 | (1) |
|
General Principles For Instituting Preventive Therapy |
|
|
165 | (1) |
|
Guidelines For Stopping Preventive Therapy |
|
|
166 | (1) |
|
Specific Migraine Preventive Agents |
|
|
167 | (9) |
|
β-Adrenergic Blockers for the Prevention of Migraine |
|
|
|
Antidepressant Medication for Migraine Prevention |
|
|
|
Calcium Channel Antagonists for the Prevention of Migraine |
|
|
|
Anti-epileptic Drugs for the Prevention of Migraine |
|
|
|
|
176 | (1) |
|
|
|
|
|
Other Drugs For The Prevention Of Migraine |
|
|
176 | (2) |
|
Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Antagonists |
|
|
|
NSAIDs and Other Complementary Treatments for Episodic Migraine Prevention in Adults |
|
|
|
Medicinal Herbs, Vitamins, And Other Interventions |
|
|
178 | (2) |
|
Herbal Preparations, Vitamins, and Minerals |
|
|
|
|
|
New Preventive Medications |
|
|
180 | (1) |
|
CGRP Antibody Antagonists[ 137] |
|
|
|
Botulinum Toxin For Migraine |
|
|
181 | (5) |
|
Formulations of Botulinum Toxin |
|
|
|
Mechanism of Action of Botulinum Toxin in Headache |
|
|
|
BoNT Treatment Techniques |
|
|
|
Clinical Studies of BoNT's Efficacy in Headache Disorders |
|
|
|
Adverse Events Associated with the Use of BoNT |
|
|
|
Appendix 1: AAN Classification Of Evidence For The Rating Of A Therapeutic Study |
|
|
186 | (1) |
|
Appendix 2: Classification Of Recommendations |
|
|
187 | (1) |
|
|
187 | (6) |
9 Chronic Migraine |
|
193 | (50) |
|
|
193 | (2) |
|
The History Of CM/TM Classification |
|
|
195 | (1) |
|
|
195 | (2) |
|
Silberstein-Lipton Criteria (1994, 1996) |
|
|
197 | (1) |
|
|
198 | (1) |
|
|
199 | (3) |
|
ICHD-3 (Beta [ P] Version) |
|
|
202 | (1) |
|
Recommendations For Diagnostic Criteria For CM/TM |
|
|
202 | (4) |
|
Differentiating CM from Other Chronic Daily Headaches |
|
|
|
Medication Overuse Headache (MOH) |
|
|
206 | (4) |
|
Definition and Classification of MOH |
|
|
|
|
|
Psychiatric Comorbidity Of CM |
|
|
210 | (2) |
|
|
212 | (1) |
|
Epidemiology Of CDH And CM |
|
|
213 | (4) |
|
|
|
|
217 | (1) |
|
|
218 | (13) |
|
|
|
|
|
Preventive Pharmacotherapy |
|
|
|
|
|
|
|
|
|
Treatment with Limited Supporting Evidence |
|
|
|
|
|
|
|
Non-pharmacological Treatment |
|
|
|
Breaking the Headache Cycle |
|
|
|
|
|
|
231 | (4) |
|
|
|
|
235 | (1) |
|
|
235 | (8) |
10 Neuromodulation |
|
243 | (16) |
|
Peripheral Nerve Stimulation |
|
|
243 | (8) |
|
Occipital Nerve Stimulation |
|
|
|
Sphenopalatine Ganglion Stimulation |
|
|
|
Supraorbital Nerve Stimulation |
|
|
|
|
|
|
251 | (3) |
|
Single-Pulse Transcranial Magnetic Stimulation |
|
|
|
Repetitive Transcranial Magnetic Stimulation (rTMS) |
|
|
|
Transcranial Direct Current Stimulation (tDCS) |
|
|
|
|
254 | (5) |
11 Hormones |
|
259 | (38) |
|
|
259 | (1) |
|
Menstruation And Migraine |
|
|
260 | (3) |
|
Treatment Of Headaches Associated With The Menstrual Cycle |
|
|
263 | (1) |
|
|
|
|
|
|
263 | (6) |
|
Migraine Associated With Hormonal Contraceptive Use |
|
|
269 | (6) |
|
|
|
Transdermal Contraceptive Patch |
|
|
|
|
|
Injectable and Implantable Hormonal Contraception |
|
|
|
|
275 | (12) |
|
|
|
|
287 | (10) |
Index |
|
297 | |